1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Viracor-IBT Laboratories Acquires Cylex

M&A Deal Summary

Viracor-IBT Laboratories Acquires Cylex

On February 1, 2013, Viracor-IBT Laboratories acquired life science company Cylex

Acquisition Highlights
  • This is Viracor-IBT Laboratories’ 1st transaction in the Life Science sector.
  • This is Viracor-IBT Laboratories’ 1st transaction in the United States.
  • This is Viracor-IBT Laboratories’ 1st transaction in Maryland.

M&A Deal Summary
Date 2013-02-01
Target Cylex
Sector Life Science
Buyer(s) Viracor-IBT Laboratories
Deal Type Add-on Acquisition
Advisor(s) SSG Capital Advisors (Financial)

Target

Cylex

Columbia, Maryland, United States
Cylex, Inc. operates as a life sciences company that develops, manufactures, and commercializes in vitro diagnostic products.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Viracor-IBT Laboratories

Lee's Summit, Missouri, United States
Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Viracor-IBT Laboratories, Inc. provides infectious disease testing, immune monitoring, and bioanalytical services to vaccine, pharmaceutical, biotech, and medical device developers.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Maryland M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2013 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal